A drug used to treat excessive daytime sleepiness may not improve driving ability in adults with obstructive sleep apnea (OSA) who cannot tolerate standard therapies, according to new research published online in the American Journal of Respiratory and Critical Care Medicine.
(Visited 7 times, 7 visits today)
- Mayo study identifies new potential treatment option for triple negative breast cancer
- New PSU study shows higher formaldehyde risk in e-cigarettes than previously thought
- Sleep better, parent better: Study shows link between maternal sleep and permissive parenting
- UCI researchers discover novel mode of neurotransmitter-based communication
- The vessel not taken: Understanding disproportionate blood flow
- New data changes the way scientists explain how cancer tumors develop
- A better way to control crystal vibrations
- Rutgers Student Interviews French Far-Right Leaders : Written by John Chadwick | ...